The EU approval of DAWNZERA is an important milestone that reflects our ongoing commitment to bring this innovative medicine to people in need across the globe
This deal marks a major step for Alteogen as it pushes its Hybrozyme platform deeper into the oncology market
The company has posted net profit of Rs. 4,064.9 crore for the 9 months period ended December 31, 2025
Aspect has acquired rights to Novo Nordisk’s stem cell-derived islet cell and hypoimmune cell engineering technologies
ATEC secures exclusive U.S. commercial rights to Theradaptive’s OsteoAdapt osteoinductive bone graft, currently in clinical trials for spinal and dental applications
Eltrombopag tablets will be produced at the group’s formulation manufacturing facility at SEZ, Ahmedabad
The updated closure system introduces intuitive handling, innovative functionality and a premium design compatible with a wide range of syringe formats
The feature will be available across all Max Healthcare facilities, offering patients consistent and convenient access to services nationwide
Dr. Reddy’s Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% is an antihistamine eye drop, indicated for the temporary relief of itchy eyes due to pollen, ragweed, grass, animal hair and dander
Subscribe To Our Newsletter & Stay Updated
